Analyst Ratings for Celldex Therapeutics (CLDX)
CLDX Rating Summary
CLDX Price Target Summary
- Highest: $100.00 (Guggenheim)
- Lowest: $34.00 (Goldman Sachs)
- Average: $54.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$54.75 (+39.5%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Avg. $ Target:
$54.75 (+39.5%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2026 | Barclays » Updated 8/7/2026 |
Etzer Darout | Upgrade | Overweight (Underweight) |
53.00 (48.00) |
33.86 (39.24) |
15.89% | Details |
| 3/23/2026 | Wolfe Research | Andy Chen | Upgrade | Outperform (Peerperform) |
44.00 (N/A) |
30.90 (39.24) |
26.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
